Stingray Healthcare Group operates a growing network of radiotherapy and radiosurgery treatment centres across Europe, bringing together leading clinicians, advanced technologies, and multidisciplinary expertise.
With more than 30 centres across eight countries, the Group enables the sharing of clinical best practices, innovation, and high-quality cancer care at scale — making it Europe’s largest independent oncology platform.
The Group delivers tens of thousands of radiotherapy treatments annually, supported by state-of-the-art linear accelerators and highly experienced multidisciplinary clinical teams.
In multidisciplinary tumour boards, close collaboration with public hospitals and oncology clinics, shared clinical knowledge across countries, AI-enhanced treatment planning and continuous investment in advanced technologies.
Centres remain locally embedded and culturally aligned with their regions, while benefiting from the strength, scale and shared expertise of the wider Group.
Stingray Healthcare Group operates a radiotherapy centre in Vienna — the first private radiotherapy facility in Austria — located within the Wiener Privatklinik, the country’s largest private hospital.
Treating Austrian and international patients, the centre works in close collaboration with Vienna University Hospital, ensuring access to the latest oncology expertise and technology.
France is one of Stingray Healthcare Group’s largest and most established markets, with an extensive network of radiotherapy centres spanning multiple regions.
Together, these centres deliver a full range of advanced cancer treatments including radiotherapy, brachytherapy, and chemotherapy to thousands of patients each year, guided by multidisciplinary teams committed to the best care.
Germany is one of Stingray Healthcare Group’s core markets, with radiotherapy and Gamma Knife radiosurgery centres operating across multiple regions.
The Group’s doctor partnership model, in which leading clinicians retain meaningful ownership alongside the Group’s strategic support, has driven continuous investment in technology and clinical excellence, establishing Stingray Healthcare Group as an established provider in one of Europe’s two largest radiotherapy markets.
In Italy, Stingray Healthcare Group operates a radiotherapy centre in Potenza, within San Carlo Azienda Ospedaliera — the principal regional hospital of the Basilicata region.
The centre delivers cancer treatment within a fully multidisciplinary setting, expanding access to high-quality cancer care for patients across the region.
In Poland, Stingray Healthcare Group operates a centre in Kraków that has been delivering specialist cancer care since 2013, treating approximately 3,000 patients per year in close collaboration with the neighbouring Ludwik Rydygier specialist hospital.
The centre offers radiotherapy, brachytherapy, and medical oncology, with all treatment decisions made within multidisciplinary tumour board meetings.
Stingray Healthcare Group operates two centres in northern Portugal — in Porto and Braga — delivering advanced radiotherapy and radiosurgery to patients across the region.
The Porto centre, located at Instituto CUF Porto, is home to Portugal’s only dedicated CyberKnife system, enabling the non-invasive treatment of both intracranial and extracranial tumours, while the Braga centre serves patients in partnership with Braga public hospital.
Romania is one of Stingray Healthcare Group’s most significant markets, with six centres — in Bucharest, Cluj-Napoca, Timișoara, Alba Iulia, Piatra Neamț, and Satu Mare — forming one of the country’s largest independent cancer care networks.
The centres offer comprehensive services including radiotherapy, brachytherapy, medical oncology, and psychological and nutritional support.
In the United Kingdom, Stingray Healthcare Group operates specialist Gamma Knife radiosurgery centres in London and Sheffield.
The London centre partners with the National Hospital for Neurology and Neurosciences at UCLH and Great Ormond Street Hospital, while Sheffield operates alongside the Royal Hallamshire Hospital’s National Stereotactic Radiosurgery Centre, together treating complex intracranial conditions with referrals from across the UK and internationally.
